oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Hycamtin

The identified deviation concerns the content parameter of the active substance topotecan; administering the medicine with an increased amount of topotecan compared to the declared dose may negatively affect treatment tolerance. Hematological toxic effects are dose‑dependent. Potential effects: hematological toxicity, complications of oncology treatment.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Hycamtin
Risk Level
High
Manufacturer
Sandoz Pharmaceuticals d.d., Verovškova ulica 57, 1000 Ljubljana, Slovenia
Batch Number
BCUN3
EAN Code
05909990643134
Recall Date
02.10.2023
View official statement

Important Information

What You Should Know

Recommendations

Do not use Hycamtin with batch numbers BCUN2 and BCUN3; if you have these packs, return them to the pharmacy and consult a doctor or pharmacist.

Actions Taken

The Chief Pharmaceutical Inspector prohibited placing Hycamtin batches BCUN2 and BCUN3 on the market throughout the country and granted the decision immediate enforceability; an explanatory procedure ...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: The identified deviation concerns the content parameter of the active substance topotecan; administering the medicine with an increased amount of topotecan compared to the declared dose may negatively affect treatment tolerance. Hematological toxic effects are dose‑dependent. Potential effects: hematological toxicity, complications of oncology treatment.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: BCUN3

Related

Other Recalled Products